other
MassBio
In network coverage since August 25, 2026 · 1 story
Network coverage
Sectors
Biopharma capital surge builds case for lab leasing rebound
Massachusetts biopharma employment declined in 2025 for the first time in two decades, but the state's VC, IPO, and M&A numbers all ran ahead in the first half of 2026 — a gap that sets up a life-science leasing recovery.